{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:28:31Z","timestamp":1793381311303,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115823","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T01:55:04Z","timestamp":1698976504000},"page":"115823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesions"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1409-5544","authenticated-orcid":false,"given":"Pouria","family":"Rahmanian-Devin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9268-6270","authenticated-orcid":false,"given":"Vahid Reza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Sanei-Far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vafa","family":"Baradaran Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3908-6828","authenticated-orcid":false,"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Golmohammadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2023.115823_bib1","article-title":"Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey","volume":"18","author":"Moradi","year":"2015","journal-title":"Arch. Iran. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.115823_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/08982104.2010.492476","article-title":"Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model","volume":"21","author":"Nagle","year":"2011","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2023.115823_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111065","article-title":"Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression","volume":"137","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115823_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105923","article-title":"Combination of imipramine, a sphingomyelinase inhibitor, and \u03b2-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE)","volume":"77","author":"Askari","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115823_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.freeradbiomed.2009.06.033","article-title":"Oxidative stress in the pathogenesis of psoriasis","volume":"47","author":"Zhou","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115823_bib8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2018.01323","article-title":"The interleukin-23\/interleukin-17 axis links adaptive and innate immunity in psoriasis","volume":"9","author":"Sch\u00f6n","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115823_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Lowes","year":"2013","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115823_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/biof.1869","article-title":"A mechanistic review on immunomodulatory effects of selective type two cannabinoid receptor \u03b2-caryophyllene","volume":"48","author":"Baradaran Rahimi","year":"2022","journal-title":"BioFactors"},{"key":"10.1016\/j.biopha.2023.115823_bib11","article-title":"A comprehensive and mechanistic review on protective effects of kaempferol against natural and chemical toxins: role of NF-\u03baB inhibition and Nrf2 activation","author":"Hosseini","year":"2022","journal-title":"BioFactors"},{"issue":"5","key":"10.1016\/j.biopha.2023.115823_bib12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/med.21357","article-title":"The noscapine chronicle: a pharmaco\u2010historic biography of the opiate alkaloid family and its clinical applications","volume":"35","author":"Rida","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2023.115823_bib13","doi-asserted-by":"crossref","first-page":"8402517","DOI":"10.1155\/2021\/8402517","article-title":"Noscapine, an emerging medication for different diseases: a mechanistic review","volume":"2021","author":"Rahmanian-Devin","year":"2021","journal-title":"Evid. Based Complement Altern. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.115823_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(88)90230-0","article-title":"Characterization of high-affinity binding sites for the antitussive [3H] noscapine in guinea pig brain tissue","volume":"145","author":"Karlsson","year":"1988","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115823_bib15","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/0008-5472.CAN-09-4230","article-title":"Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-\u03baB signaling pathwaynoscapine sensitizes leukemic cells through NF-\u03baB","volume":"70","author":"Sung","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.115823_bib16","author":"KHAKPOUR","year":"2005","journal-title":"The effect of noscapine on carrageenan-induced inflammation in rat"},{"issue":"5","key":"10.1016\/j.biopha.2023.115823_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.6026\/97320630014236","article-title":"Comparative evaluation of anti-angiogenic effects of noscapine derivatives","volume":"14","author":"Meher","year":"2018","journal-title":"Bioinformation"},{"key":"10.1016\/j.biopha.2023.115823_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.colsurfb.2015.05.022","article-title":"Wheat germ agglutinin anchored chitosan microspheres of reduced brominated derivative of noscapine ameliorated acute inflammation in experimental colitis","volume":"132","author":"Kaur","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.biopha.2023.115823_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3707647","article-title":"Topical formulation of noscapine, a benzylisoquinoline alkaloid, ameliorates imiquimod-induced psoriasis-like skin lesions","volume":"2022","author":"Nourbakhsh","year":"2022","journal-title":"Evid. - Based Complement. Altern. Med."},{"issue":"3","key":"10.1016\/j.biopha.2023.115823_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.biopha.2023.115823_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1337-8","article-title":"Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability","volume":"20","author":"Talegaonkar","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2023.115823_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejpb.2015.06.020","article-title":"Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route","volume":"97","author":"Lauterbach","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2023.115823_bib24","series-title":"Hansen Solubility Parameters: A User's Handbook","author":"Hansen","year":"2007"},{"key":"10.1016\/j.biopha.2023.115823_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.fhfh.2021.100024","article-title":"Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active","volume":"1","author":"Sakellari","year":"2021","journal-title":"Food Hydrocoll. Health"},{"issue":"4","key":"10.1016\/j.biopha.2023.115823_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115823_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jsps.2020.01.010","article-title":"The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds","volume":"28","author":"Makoni","year":"2020","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.biopha.2023.115823_bib28","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.2147\/IJN.S211130","article-title":"Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity","volume":"14","author":"Zhang","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/02652048.2018.1425753","article-title":"Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation","volume":"35","author":"El-Salamouni","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.biopha.2023.115823_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.15102","article-title":"Preparation, characterization and evaluation of anti\u2010tyrosinase activity of solid lipid nanoparticles (SLNs) containing Undecylenoyl phenylalanine (Sepiwhite\u00ae)","author":"Kabiri","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115823_bib31","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/jps.23522","article-title":"Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations","volume":"102","author":"Mosallaei","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115823_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12247-018-9318-0","article-title":"Optimization of noscapine-loaded mPEG-PLGA nanoparticles and release study: a response surface methodology approach","volume":"13","author":"Esnaashari","year":"2018","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.biopha.2023.115823_bib33","article-title":"A review of in vitro drug release test methods for nano-sized dosage forms","volume":"2014","author":"D\u2019Souza","year":"2014","journal-title":"Adv. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib34","first-page":"97","article-title":"Noscapine loaded PLGA nanoparticles prepared using oil-in-water emulsion solvent evaporation method","volume":"3","author":"Yadav","year":"2016","journal-title":"J. Nanopharm. Drug Deliv."},{"issue":"10","key":"10.1016\/j.biopha.2023.115823_bib35","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3390\/molecules24102024","article-title":"Preparation, in vivo and in vitro release of polyethylene glycol monomethyl ether-polymandelic acid microspheres loaded panax notoginseng saponins","volume":"24","author":"He","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2023.115823_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2478\/v10007-012-0032-z","article-title":"Improved photostability, reduced skin permeation and irritation of isotretinoin by solid lipid nanoparticles","volume":"62","author":"Golmohammadzadeh","year":"2012","journal-title":"Acta Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.115823_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08923973.2013.862542","article-title":"A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model","volume":"36","author":"Sun","year":"2014","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/08982104.2019.1593449","article-title":"Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis","volume":"30","author":"Walunj","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2023.115823_bib40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2023.115823_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116595","article-title":"Ellagic acid dose and time-dependently abrogates d-galactose-induced animal model of aging: Investigating the role of PPAR-gamma","volume":"232","author":"Baradaran Rahimi","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115823_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/biof.1942","article-title":"Crocetin regulates Th1\/Th2 and Th17\/Treg balances, nitric oxide production, and nuclear localization of NF-\u03baB in Th2-provoked and normal situations in human-isolated lymphocytes","author":"Baradaran Rahimi","year":"2023","journal-title":"Biofactors"},{"key":"10.1016\/j.biopha.2023.115823_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2620710","article-title":"Acetyl-11-Keto-\u03b2-Boswellic acid (AKBA) prevents lipopolysaccharide-induced inflammation and cytotoxicity on H9C2 cells","volume":"2022","author":"Taherzadeh","year":"2022","journal-title":"Evid. - Based Complement. Altern. Med."},{"issue":"18","key":"10.1016\/j.biopha.2023.115823_bib44","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.3390\/molecules27186075","article-title":"Protective effect of portulaca oleracea on streptozotocin-induced type I diabetes-associated reproductive system dysfunction and inflammation","volume":"27","author":"Rakhshandeh","year":"2022","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.biopha.2023.115823_bib45","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1569::AID-CNCR19>3.0.CO;2-M","article-title":"The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2","volume":"85","author":"Kallakury","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/030089160409000124","article-title":"p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases","volume":"90","author":"Batinac","year":"2004","journal-title":"Tumori"},{"issue":"7","key":"10.1016\/j.biopha.2023.115823_bib47","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharm."},{"issue":"21","key":"10.1016\/j.biopha.2023.115823_bib48","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1002\/cphc.201700408","article-title":"Revisiting Hansen solubility parameters by including thermodynamics","volume":"18","author":"Louwerse","year":"2017","journal-title":"ChemPhysChem"},{"issue":"12","key":"10.1016\/j.biopha.2023.115823_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-013-2124-1","article-title":"Evaluation of bioavailability, efficacy, and safety profile of doxorubicin-loaded solid lipid nanoparticles","volume":"15","author":"Patro","year":"2013","journal-title":"J. Nanopart. Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115823_bib50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nano.2012.10.003","article-title":"Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells","volume":"9","author":"Madan","year":"2013","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.115823_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.15533","article-title":"IL-17A and IL-22 producing neutrophils in psoriatic skin, The","volume":"177","author":"Dyring-Andersen","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115823_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.1992.tb07805.x","article-title":"Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines?","volume":"126","author":"Baker","year":"1992","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115823_bib53","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI200316750","article-title":"Anti-inflammatory properties of the \u03bc opioid receptor support its use in the treatment of colon inflammation","volume":"111","author":"Philippe","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"45","key":"10.1016\/j.biopha.2023.115823_bib54","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1016\/j.chroma.2011.09.030","article-title":"Screening and characterization of natural antioxidants in four Glycyrrhiza species by liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry","volume":"1218","author":"Li","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.biopha.2023.115823_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115823_bib56","first-page":"4090","article-title":"A review on solid lipid nanoparticles; focus on excipients and formulation techniques","author":"Anjum","year":"2019","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.biopha.2023.115823_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ifset.2013.03.002","article-title":"Nanostructured lipid carriers (NLC): a potential delivery system for bioactive food molecules","volume":"19","author":"Tamjidi","year":"2013","journal-title":"Innov. Food Sci. Emerg. Technol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115823_bib58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1166\/jbn.2009.1042","article-title":"Lipid nanomedicines for anticancer drug therapy","volume":"5","author":"de Mendoza","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2023.115823_bib59","first-page":"FL","article-title":"Characterization of solid lipid nano-and microparticles","author":"Bunjes","year":"2005","journal-title":"CRC Press.: Boca Raton"},{"key":"10.1016\/j.biopha.2023.115823_bib60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejpb.2016.09.008","article-title":"Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery","volume":"108","author":"Qureshi","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.biopha.2023.115823_bib61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/gels8050277","article-title":"Hydrogel containing solid lipid nanoparticles loaded with argan oil and simvastatin: preparation, in vitro and ex vivo assessment","volume":"8","author":"Khan","year":"2022","journal-title":"Gels"},{"issue":"8","key":"10.1016\/j.biopha.2023.115823_bib62","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1365-2222.2008.03037.x","article-title":"Immunoregulatory roles of eosinophils: a new look at a familiar cell","volume":"38","author":"Akuthota","year":"2008","journal-title":"Clin. Exp. Allergy"},{"issue":"3\u20134","key":"10.1016\/j.biopha.2023.115823_bib63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1556\/APhysiol.88.2001.3-4.5","article-title":"Efffect of noscapine, the antitussive opioid alkaloid, on bradykinin-induced smooth muscle contraction in the isolated ileum of the guinea-pig","volume":"88","author":"Mahmoudian","year":"2001","journal-title":"Acta Physiol. Hung."},{"issue":"10","key":"10.1016\/j.biopha.2023.115823_bib64","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.4236\/jmp.2020.1110094","article-title":"Multiple emulsions able to be used for oral administration of active pharmaceutical ingredients: physico-chemical parameters study of different phases","volume":"11","author":"Diouf","year":"2020","journal-title":"J. Mod. Phys."},{"key":"10.1016\/j.biopha.2023.115823_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121706","article-title":"Poloxamer 188 as surfactant in biological formulations\u2013an alternative for polysorbate 20\/80?","author":"Bollenbach","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1208\/s12249-009-9199-0","article-title":"Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery","volume":"10","author":"Bhalekar","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"10.1016\/j.biopha.2023.115823_bib67","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00403-006-0713-x","article-title":"Influence of pH on wound-healing: a new perspective for wound-therapy?","volume":"298","author":"Schneider","year":"2007","journal-title":"Arch. Dermatol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115823_bib68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0168-3659(02)00056-1","article-title":"Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration","volume":"81","author":"Wissing","year":"2002","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biopha.2023.115823_bib69","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/ma12050730","article-title":"Conductomeric evaluation of the release kinetics of active substances from pharmaceutical preparations containing iron ions","volume":"12","author":"Lisik","year":"2019","journal-title":"Materials"},{"issue":"19","key":"10.1016\/j.biopha.2023.115823_bib70","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.biopha.2023.115823_bib71","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00709-015-0829-y","article-title":"Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants","volume":"253","author":"Arora","year":"2016","journal-title":"Protoplasma"},{"key":"10.1016\/j.biopha.2023.115823_bib72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2018\/7931031","article-title":"Antipsoriatic effects of wannachawee recipe on imiquimod-induced psoriasis-like dermatitis in BALB\/c Mice","volume":"2018","author":"Na Takuathung","year":"2018","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.115823_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067078","article-title":"Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice","volume":"8","author":"Sun","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2023.115823_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621956","article-title":"Major role of the IL17\/23 axis in psoriasis supports the development of new targeted therapies","volume":"12","author":"Bugaut","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115823_bib75","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/2475530318810851","article-title":"TNF inhibitor-induced psoriasis: proposed algorithm for treatment and management","volume":"4","author":"Li","year":"2019","journal-title":"J. Psoriasis psoriatic Arthritis"},{"key":"10.1016\/j.biopha.2023.115823_bib76","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00063030-200519010-00006","article-title":"TNF\u03b1 inhibitors in the treatment of psoriasis and psoriatic arthritis","volume":"19","author":"Tobin","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.biopha.2023.115823_bib77","first-page":"415","article-title":"Transforming growth factor-\u03b21 gene polymorphism in psoriasis vulgaris","author":"El-Hadidi","year":"2018","journal-title":"Clin. Cosmetic Invest. Dermatol."},{"issue":"24","key":"10.1016\/j.biopha.2023.115823_bib78","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.3390\/jcm10245834","article-title":"An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R expression and their correlation with clinical course in patients with psoriasis","volume":"10","author":"Kutwin","year":"2021","journal-title":"J. Clin. Med."},{"issue":"9997","key":"10.1016\/j.biopha.2023.115823_bib79","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet (Lond. Engl.)"},{"issue":"4","key":"10.1016\/j.biopha.2023.115823_bib80","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5021\/ad.2018.30.4.485","article-title":"Differential effects of digoxin on imiquimod-induced psoriasis-like skin inflammation on the ear and back","volume":"30","author":"Madsen","year":"2018","journal-title":"Ann. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115823_bib81","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/biores.2014.0022","article-title":"Study of in vitro capillary-like structures in psoriatic skin substitutes","volume":"3","author":"Ayata","year":"2014","journal-title":"BioResearch Open Access"},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-020-00089-x","article-title":"Exploring the multiple roles of guardian of the genome: P53","volume":"21","author":"Feroz","year":"2020","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"4","key":"10.1016\/j.biopha.2023.115823_bib83","doi-asserted-by":"crossref","DOI":"10.1051\/bmdcn\/2019090426","article-title":"Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis","volume":"9","author":"Ramezani","year":"2019","journal-title":"Biomedicine"},{"issue":"4","key":"10.1016\/j.biopha.2023.115823_bib84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1051\/bmdcn\/2019090426","article-title":"Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis","volume":"9","author":"Ramezani","year":"2019","journal-title":"BioMedicine"},{"issue":"8","key":"10.1016\/j.biopha.2023.115823_bib85","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.prp.2006.04.004","article-title":"Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma","volume":"202","author":"Batinac","year":"2006","journal-title":"Pathol. - Res. Pract."},{"issue":"1","key":"10.1016\/j.biopha.2023.115823_bib86","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0377-4929.94857","article-title":"Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt","volume":"55","author":"Amin","year":"2012","journal-title":"Indian J. Pathol. Microbiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:21:33Z","timestamp":1779916893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223016219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":86,"alternative-id":["S0753332223016219"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115823","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesions","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115823"}}